Pricing Log in Create free account

aTyr Pharma, Inc. (ATYR) vs Cocrystal Pharma, Inc. (COCP)

aTyr Pharma, Inc. and Cocrystal Pharma, Inc. are both Biotechnology companies. Cocrystal Pharma, Inc. is the larger, with a market value of $19.8M against $18.0M — 1.1× the size. aTyr Pharma, Inc. grew revenue faster over the last twelve months: 6.78% against −30.4%. aTyr Pharma, Inc. has the higher net margin (0.00% vs −747.8%) and the higher return on invested capital (0.00% vs 0.00%). Across the 17 metrics below, aTyr Pharma, Inc. leads on 11 and Cocrystal Pharma, Inc. on 6.

Valuation

Metric ATYR COCP Biotechnology median
P/E n/m n/m 8.50
P/S 1.49 10.58 9.71
P/B 0.34 13.47 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.59 n/m 0.64
EV/Sales (3.37) 8.90 9.21
Earnings yield (364.71%) (74.51%) (33.15%)
Free cash flow yield (328.74%) (56.64%) (25.50%)

Profitability

Metric ATYR COCP Biotechnology median
Gross margin 1.72% 9.10% 65.16%
Operating margin 0.00% (760.72%) 0.00%
Net margin 0.00% (747.78%) 0.00%
Free cash flow margin 0.00% (598.50%) 0.00%
Return on equity (98.67%) (311.68%) (56.36%)
Return on assets (70.97%) (151.10%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ATYR COCP Biotechnology median
Revenue growth (TTM) 6.78% (30.38%) 6.02%
EPS growth (last fiscal year) 6.98% 54.65% 30.26%
Revenue growth, 5-year CAGR (14.75%) (33.30%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ATYR COCP Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.12 1.24 4.72
Net debt to EBITDA 1.01 0.82 0.96

Dividend

Metric ATYR COCP Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ATYR COCP Biotechnology median
Market cap 18.03m 19.84m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack